RE: Potential role of cannabis in ameliorating observed racialized disparities in cancer pain management
JNCI: Journal of the National Cancer Institute · 2024
DOI: 10.1093/jnci/djae090 ↗Kurz gefasst
Leserbrief in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Raffaele Giusti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy. Hauptthemen laut MEDLINE: Cancer Pain, Pain Management, Healthcare Disparities, Medical Marijuana. Die Arbeit nennt 1 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Dear Editor, We read the insightful analysis presented in the article “Potential Role of Cannabis in Ameliorating Observed Racialized Disparities in Cancer Pain Management” from Gibson et al. (1). The authors effectively highlight the crucial issue of undertreated pain among racialized cancer patients and explore the potential of medical cannabis to address this disparity. The article provides a comprehensive overview of racial disparities in cancer pain management and the potential role of cannabis in mitigating these disparities. The authors rightly discuss the complex structural, systemic, and interpersonal barriers that racialized cancer patients face in accessing medical cannabis. Additionally, they emphasize the importance of considering the ethical and legal implications of cannabis use for cancer pain. We agree with the authors that medical cannabis may have a role in mitigating racial disparities in cancer pain management. However, we would like to highlight a few points in this letter. It is important to emphasize that research on the efficacy and safety of cannabis for cancer pain is still ongoing. More rigorous clinical trials, particularly with racially diverse patient samples, are needed to determine the effectiveness of cannabis in treating cancer pain. Moreover, the current research lacks sufficient data on optimal dosing regimens for medical cannabis in the context of cancer pain. Studies exploring the interaction between cannabis and traditional pain medications are also crucial, particularly for patients with complex pain presentations. Further research is necessary to determine the specific types of cancer pain that may respond favorably to cannabis treatment. This will allow for a more targeted approach and optimize pain management strategies for racialized patients. As discussed by the authors, racialized cancer patients may face significant barriers to accessing medical cannabis, including high costs, lack of insurance coverage, and social stigma. It is critical that policies and laws are changed to ensure equitable and safe access to medical cannabis for all patients who need it. To address the issue of stigma and encourage informed decision-making, culturally competent education initiatives for both patients and health-care providers are essential. This will empower racialized patients to navigate the complexities of medical cannabis use and ensure health-care providers can offer culturally sensitive guidance. Finally, cancer pain management should be a holistic approach that includes a variety of interventions, including medications, physical therapy, and psychological support. In conclusion, the Gibson et al. (1) article offers a valuable springboard for further investigation into the potential of medical cannabis to bridge the gap in cancer pain management for racialized populations. By addressing the research gaps outlined above and prioritizing culturally sensitive education, we can move closer to achieving equitable and evidence-based pain management for all cancer patients. Through collaborative efforts to address these research gaps and promote culturally sensitive education, we can move toward achieving equitable and evidence-based pain management for all cancer patients. This will require a concerted effort from researchers, clinicians, policymakers, and patient advocates to ensure that all patients have access to safe and effective pain management options, regardless of their race or ethnicity. Data sharing is not applicable to this article, as no new data were created or analyzed in this study. Raffaele Giusti, MD (Conceptualization; Data curation; Writing—original draft; Writing—review & editing), Giampiero Porzio, MD (Supervision; Validation). No funding was received for this article. No competing financial interests exist.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Oncology Unit, Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy.
- Tuscany Tumors Association, Home Care Service, Florence, Italy.
ORCID-Profile: Raffaele Giusti
Zitieren
APA
Giusti, R., & Porzio, G. (2024). RE: Potential role of cannabis in ameliorating observed racialized disparities in cancer pain management. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae090
Vancouver
Giusti R, Porzio G. RE: Potential role of cannabis in ameliorating observed racialized disparities in cancer pain management. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae090
BibTeX
@article{Giusti2024,
author = {Giusti, Raffaele and Porzio, Giampiero},
title = {RE: Potential role of cannabis in ameliorating observed racialized disparities in cancer pain management},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
doi = {10.1093/jnci/djae090}
}
EUVIMED